SB 590885 is a selective serotonin and dopamine reuptake inhibitor that functions as a dual-mechanism antidepressant, primarily indicated for the treatment of major depressive disorder. By inhibiting the… Read more
SB 590885 is a selective serotonin and dopamine reuptake inhibitor that functions as a dual-mechanism antidepressant, primarily indicated for the treatment of major depressive disorder. By inhibiting the reuptake of serotonin and dopamine, this compound helps elevate their concentrations within the synaptic cleft to mitigate the symptoms of depression. To ensure the rigorous quality control and accurate analysis of this therapeutic agent, pharmaceutical laboratories rely on high-quality reference standards. The available collection includes essential impurities, metabolites, and stable isotope-labelled standards designed for precise impurity profiling, method validation, and pharmacokinetic studies. These critical analytical tools allow researchers and analysts to identify potential degradation products and quantify active drug content with precision throughout the pharmaceutical development cycle.